Transaction DateRecipientSharesTypePriceValue
11th November 2020Richard J Berman20,000Open or private sale$55.55$1,110,934.00
11th November 2020Richard J Berman11,700Exercise of derivative$4.56$53,352.00
11th November 2020Richard J Berman8,300Exercise of derivative$3.07$25,481.00
30th September 2020Edward J Zecchini192Grant/award etc.$47.82$9,181.44
30th September 2020Daniel M Hancock240Grant/award etc.$47.82$11,476.80
29th July 2020Richard J Berman8,138Exercise of in-the-money or at-the-money derivatives securities (usually options)$3.57$29,052.66
20th July 2020Robert J Hariri15,300Exercise of in-the-money or at-the-money derivatives securities (usually options)$3.57$54,621.00
30th June 2020Edward J Zecchini310Grant/award etc.$29.54$9,157.40
30th June 2020Daniel M Hancock389Grant/award etc.$29.54$11,491.06
28th May 2020Richard J Berman1,112Exercise of in-the-money or at-the-money derivatives securities (usually options)$6.00$6,672.00
Cryoport
Cryoport logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.


Ticker: CYRX
Sector: Industrials
Industry: Integrated Freight & Logistics
SEC Central Index Key (CIK): 1124524
Employees: 92
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $44 M (0%)
Inventory, Net: $538 Th (13%)
Assets, Current: $217 M (110%)
Property, Plant and Equipment, Net: $14 M (15%)
Assets: $253 M (0%)
Liabilities, Current: $9 M (72%)
Liabilities: $126 M (1214%)
Common Stock, Value, Issued: $39 Th (3%)
Common Stock, Shares, Issued: $39 M (3%)
Additional Paid in Capital, Common Stock: $295 M (3%)
Retained Earnings (Accumulated Deficit): $169 M (6%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $260 Th (477%)
Stockholders' Equity (Parent): $127 M (0%)
Liabilities and Equity: $253 M (86%)
Gross Margin: $5 M (-50%)
Research and Development: $2 M (-47%)
Sales and Marketing: $3 M (-48%)
General and Administrative Expenses: $6 M (-41%)
Operating Income/Loss: $6 M (0%)
Income before taxes: $6 M (-40%)
Provision for income taxes: $50 Th (-39%)